Drug intelligence / Profile preview

Benefit Qi Nourish Yin Formula

Development stage: Preclinical
Lead developer: Chengdu University of Traditional Chinese Medicine
Administration: Oral

Overview

Benefit Qi Nourish Yin Formula is a Traditional Chinese Medicine (TCM) formula presented in granule form. It is currently under investigation in a clinical trial for the treatment of Non-proliferative diabetic retinopathy. The formula is administered orally and is being evaluated against a placebo in a cross-over study design to assess its clinical efficacy.

Other names: Formula of T.C.M: benefit qi nourish Yin formula (granule )益气养阴中药复方益气养阴中药复方（颗粒）

Beyond the preview

Go deeper on Benefit Qi Nourish Yin Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benefit Qi Nourish Yin Formula.

Explore the full profile